Parkinson's disease:
Personalised Cellular treatment

T-regulatory cells
(T-regs)

T-regulatory cells (T-regs) are specialised immune cells responsible for maintaining immune balance and preventing excessive or destructive inflammatory responses, particularly within the central nervous system.

​

In Parkinson’s Disease, T-regs play a critical role in suppressing chronic neuroinflammatory activity that contributes to progressive dopaminergic neuron dysfunction and disruption of motor control pathways.

​

At BioCells Medical, T-reg therapy is delivered through a personalised protocol based on either autologous cells (patient-derived) or carefully selected allogeneic cells (donor-derived), depending on clinical indications, immune profile and disease dynamics. The objective is to precisely recalibrate immune regulation and restore long-term neuro-immune stability.

​

Through targeted immune recalibration, T-reg therapy is designed to stop immune-driven functional deterioration, stabilise neurological and motor function, and reduce symptom burden such as rigidity, fatigue, motor fluctuations and mobility impairment in selected patients.

Purified concentrated 
exosomes

Purified exosomes are nanoscale biological vesicles naturally released by regenerative cells, containing concentrated growth factors, regulatory proteins and micro-RNAs involved in cellular repair and intercellular communication.

​

In Parkinson’s Disease, exosomes function as molecular messengers that influence key disease-related processes by reducing oxidative stress, modulating neuroinflammatory signaling and supporting metabolic activity within dopaminergic and surrounding neural cells.

​

At BioCells Medical, exosomes are produced in our laboratory as highly purified, concentrated formulations, ensuring consistent bioactivity, controlled composition and a high safety profile prior to clinical application.

​

Acting at a molecular level, purified exosomes are designed to interrupt degenerative signaling pathways, enhance neural efficiency and metabolic resilience, and improve motor coordination, endurance and neurological responsiveness — contributing to measurable functional improvement and sustained stability across different stages of Parkinson’s Disease.

Personalised Neurostimulation Therapy

Neurostimulation is a non-invasive medical technology that delivers precisely controlled electrical impulses to targeted regions of the brain and spinal cord.

​

In Parkinson’s Disease, neurostimulation is used to modulate dysfunctional motor circuits, enhance neural signaling within basal ganglia–cortical pathways and improve communication between the central nervous system and peripheral motor systems.

​

At BioCells Medical, neurostimulation is integrated into a personalised therapeutic protocol and applied according to the patient’s neurological profile, motor symptoms and disease stage, with the goal of optimising neural responsiveness and reinforcing functional recovery.

​

By modulating neural circuits and restoring more physiological signaling patterns, neurostimulation aims to stop progressive loss of motor control, reduce rigidity and bradykinesia, improve gait, balance and movement fluidity, and restore a stronger sense of body stability and voluntary functional control.

Peptide-Based
Protocol

Peptide therapy utilises precisely engineered biological molecules that function as cell-to-cell messengers, restoring disrupted communication within the nervous and immune systems.

​

In Parkinson’s Disease, targeted peptides are applied to optimise mitochondrial function, support cellular energy production and protein synthesis, and regulate metabolic and inflammatory pathways that contribute to dopaminergic neuron stress, motor fatigue and disease progression.

​

At BioCells Medical, peptide therapy is incorporated into a personalised therapeutic plan through custom-tailored formulations, selected according to the patient’s metabolic profile, neurological status and disease stage, with the objective of reinforcing long-term neuroprotective and metabolic stability.

​

By optimising cellular signaling and energy regulation, peptide therapy aims to stop metabolic-driven functional decline, reduce fatigue and motor fluctuations, enhance muscle endurance and cognitive clarity, and maintain sustained energy balance — strengthening overall neurological performance and daily functional capacity.